A Novel Peptide Mapping Method Utilizing Cysteine as a Reducing Agent
- PMID: 39849215
- DOI: 10.1007/s11095-024-03805-z
A Novel Peptide Mapping Method Utilizing Cysteine as a Reducing Agent
Abstract
Purposes: In the peptide mapping reduction process for monoclonal antibodies (mAbs) and other proteins, the conventional reducing reagents β-mercaptoethanol (β-ME) and dithiothreitol (DTT) pose challenges due to their strong odor and toxicity at high concentrations. Cysteine (Cys), an essential amino acid for new protein synthesis, is an overlooked, nontoxic, and odorless reducing agent. This study presents a novel peptide mapping method using Cys as the reducing agent.
Methods: We explored the reducing effect of Cys at different concentrations and pH levels for peptide mapping analysis of a specific mAb (mAb-1), using DTT as a positive control. RP-HPLC analysis, including UV chromatogram comparison and overall similarity calculation, was conducted for comparison. LC-MS analysis was subsequently utilized to characterize the primary sequence of mAb-1. We also applied the method to other mAbs or proteins to demonstrate its wide applicability.
Results: The UV chromatogram and overall similarity of Cys as a reducing agent at concentrations ranging from 10 to 40 mM and pH levels between 7.0 and 11.0 were consistent with those of the positive control. Reduced concentrations of Cys or lower pH levels compromised reducing efficacy. This novel reducing method proficiently characterized the primary sequence of mAb-1, achieving an overall sequence coverage of 97%. In the analysis of other mAbs or proteins, the peptide mapping results also showed high consistency.
Conclusions: Cys exhibits a reducing ability comparable to DTT and possesses the advantageous characteristics of being nontoxic and odorless, making it a potential alternative for disulfide bond reduction and peptide mapping analysis of proteins and mAbs.
Keywords: cysteine; dithiothreitol; monoclonal antibody; peptide mapping; reducing agent.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflicts of Interests: The authors have no conflicts of interest to declare.
Similar articles
-
Complete disulfide bond assignment of a recombinant immunoglobulin G4 monoclonal antibody.Anal Biochem. 2002 Dec 1;311(1):1-9. doi: 10.1016/s0003-2697(02)00394-9. Anal Biochem. 2002. PMID: 12441146
-
Identification of an acetonitrile addition impurity formed during peptide disulfide bond reduction using dithiothreitol and Tris(2-carboxyethyl)phosphine.J Pharm Biomed Anal. 2019 Sep 10;174:518-524. doi: 10.1016/j.jpba.2019.06.020. Epub 2019 Jun 19. J Pharm Biomed Anal. 2019. PMID: 31252308
-
Application of HPLC-ESI-ITMS in the quality control of carboxyterminal sequence confirmation for the recombinant DNA product Hirudin Variant 3.J Pharm Biomed Anal. 2007 Jan 17;43(2):533-9. doi: 10.1016/j.jpba.2006.08.009. Epub 2006 Dec 1. J Pharm Biomed Anal. 2007. PMID: 17141443
-
Expression and mutagenesis of the novel serpin endopin 2 demonstrates a requirement for cysteine-374 for dithiothreitol-sensitive inhibition of elastase.Biochemistry. 2000 Aug 1;39(30):8944-52. doi: 10.1021/bi9929655. Biochemistry. 2000. PMID: 10913307
-
Removal of the fluorescent 4-(aminosulfonyl)-2,1,3-benzoxadiazole label from cysteine-containing peptides.J Chromatogr A. 1998 Mar 6;798(1-2):47-54. doi: 10.1016/s0021-9673(97)00875-3. J Chromatogr A. 1998. PMID: 9542125
References
-
- Qu M, An B, Shen S, Zhang M, Shen X, Duan X, et al. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry. Mass Spectrom Rev. 2017;36(6):734–54. https://doi.org/10.1002/mas.21500 . - DOI - PubMed
-
- Zhang G, Annan RS, Carr SA, Neubert TA. Overview of peptide and protein analysis by mass spectrometry. Curr Protoc Protein Sci. 2010;Chapter 16:Unit16.1. https://doi.org/10.1002/0471140864.ps1601s62 .
-
- Ruegg CL, Anderson-Berg WT, Brechbiel MW, Mirzadeh S, Gansow OA, Strand M. Improved in vivo stability and tumor targeting of bismuth-labeled antibody. Cancer Res. 1990;50(14):4221–6. - PubMed
-
- Giansanti P, Tsiatsiani L, Low TY, Heck AJ. Six alternative proteases for mass spectrometry-based proteomics beyond trypsin. Nat Protoc. 2016;11(5):993–1006. https://doi.org/10.1038/nprot.2016.057 . - DOI - PubMed
-
- Kašička V. Peptide mapping of proteins by capillary electromigration methods. J Sep Sci. 2022;45(23):4245–79. https://doi.org/10.1002/jssc.202200664 . - DOI - PubMed
MeSH terms
Substances
Grants and funding
- LHDMZ24H300003/Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China
- 24gya05/Taizhou Science and Technology Plan Projects
- 2024TZSX105/Municipal-University Cooperation Projects of Taizhou Institute of Zhejiang University
- 2023-1-120/Jinhua Science and Technology Plan Projects
LinkOut - more resources
Full Text Sources